Status:
UNKNOWN
Neurogenic Myocardial and Lung Injury in SAH Patients
Lead Sponsor:
Medical University of Silesia
Conditions:
Myocardial Injury
Lung Injury
Eligibility:
All Genders
18+ years
Brief Summary
Up to this day, little is known whether the extent of brain damage in patients with SAH correlates with the degree neurogenic myocardial injury and neurogenic lung injury. This is a prospective obser...
Detailed Description
Multiple forms of brain damage, primarily, subarachnoid haemorrhage (SAH) are frequently accompanied by neurogenic myocardial injury with changes in the electrocardiogram, accompanied by the release o...
Eligibility Criteria
Inclusion
- patients with subarachnoid haemorrhage (both aneurysmal and non-aneurysmal) with acute consciousness disturbances (Glasgow Coma Scale \< 8 pts) requiring intubation and mechanical ventilation, hospitalized in the ICU for over 24 hours
Exclusion
- severe prior pulmonary diseases
- severe prior cardiac diseases
- death in the first 72 hours of ICU stay
- need for any extracorporeal life-saving techniques
Key Trial Info
Start Date :
January 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05408988
Start Date
January 22 2022
End Date
December 31 2024
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinical Center prof. K. Gibiński of the Medical University of Silesia in Katowice
Katowice, Silesian Voivodeship, Poland, 40-752